Related Deals
Related Parents
Related Issuers
by Stephen Carter
Dec 02, 2025 8:01 AM ET
Almirall SA (ALMSM) EUR250m Reg S only sr notes due 2031 (5.5y). NC2 (50%,25%,par). (Expect Ba2)/BB+ (stable/stable). Via BNP/JPM (B&D) jt glocos and physical books/BBVA/BofA/Caixa/Santander jt books. List Lux. NY law. Denoms:100kx1k.
IPT: low 4s.
Roadshow (small group meetings) 12/02-03 (investor call 11am UKT 12/02). Pricing 12/03. UOP: along with EUR55m cash on hand, to redeem its EUR300m 2.125% sr notes due 09/30/26 (callable at 100). Biz: a publicly listed pharmaceutical company that researches, develops, produces and markets a fairly diversified portfolio of in-house developed drugs and in-licensed drugs in therapeutic areas including dermatology, respiratory, gastrointestinal and pain relief. HQ: Barcelona, Spain.
Netroadshow direct link: https://www.netroadshow.com/nrs/home/#!/?show=a364261a. Entry code: HEALTH25.